BfArM - Federal Institute for Drugs and Medical Devices

Navigation and service

Dear Doctor Letter (Rote-Hand-Brief) on ZERIT® (stavudine): Restricted indications

Active substance: stavudine

Important information on restrictions in the indications of ZERIT® (stavudine) due to potentially serious adverse reactions.

Download DHPC / Information letter , Download_VeroeffentlichtAm_EN PDF, 419KB, File is accessible